C9141 Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.

Short descriptor: Factor viii pegylated-aucl

⚠ Terminated HCPCS Level II 2026
Terminated Code
C9141 was terminated as of 2019-06-30 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open C9141 in the app →

Look up C9141 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

C9141 is the HCPCS Level II code for Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u. (2026). It belongs to Section C — Outpatient PPS (Hospital). Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Statute.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Statute (indicator 53)
Type of Service
Other medical items or services
Effective Date
2019-07-01
Termination Date
2019-06-30
2026 Maintenance
No change this year

References

Cite This Page

Reference C9141 with the canonical source and edition:

C9141 — Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/C9141

Canonical URL: https://icd10codingpro.com/hcpcs-codes/C9141

Related Codes in Section C

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial